Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
186.71
Nov 20 • 3:59 PM ET Dollar change-3.65 Percentage change(-1.92%)
Aftermarket Close
186.71
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
13.99B
Enterprise Value
16.69B
Income
448.66M
Sales
8.23B
Book/sh
121.83
Cash/sh
10.80
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
40100
IPO
May 15, 1998
P/E
32.18
Forward P/E
16.07
PEG
9.46
P/S
1.70
P/B
1.53
P/C
17.29
P/FCF
16.86
EV/EBITDA
13.91
EV/Sales
2.03
Quick Ratio
1.32
Current Ratio
1.32
Debt/Eq
0.38
LT Debt/Eq
0.38
Option/Short
Yes / Yes
EPS (ttm)
5.80
EPS next Y
11.62
EPS next Q
2.83
EPS this Y
-15.55%
EPS next Y
9.77%
EPS next 5Y
1.70%
EPS past 3/5Y
-22.33% -14.31%
Sales past 3/5Y
2.15% 24.15%
EPS Y/Y TTM
43.70%
Sales Y/Y TTM
0.67%
EPS Q/Q
142.96%
Sales Q/Q
-2.86%
Insider Own
1.05%
Insider Trans
-5.34%
Inst Own
104.17%
Inst Trans
-3.88%
ROA
2.77%
ROE
4.95%
ROIC
3.56%
Gross Margin
18.99%
Oper. Margin
9.62%
Profit Margin
5.45%
SMA20
-6.46%
SMA50
2.68%
SMA200
26.75%
Trades
Shs Outstand
74.92M
Shs Float
74.13M
52W High
219.04 -14.76%
52W Low
66.57 180.47%
Volatility
3.81% 4.11%
ATR (14)
8.13
RSI (14)
44.58
Beta
1.19
Rel Volume
0.75
Avg Volume
977.00K
Volume
735,236
Perf Week
-4.08%
Perf Month
0.69%
Perf Quarter
7.63%
Perf Half Y
59.88%
Perf YTD
2.46%
Perf Year
18.08%
Perf 3Y
-30.85%
Perf 5Y
-34.76%
Perf 10Y
144.99%
Prev Close
190.36
Price
186.71
Change %
-1.92%
Consensus
Buy
Avg. Price Target
$234.56
Implied Upside
+25.6%
Analysts12incl. previous ratings
Rating Distribution6 Buy · 6 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 09, 2026Upgrade
BAC logoBBofA Securities
Underperform → Neutral$185-0.9%
Sep 30, 2026Resumed
UBS logoUUBS
Neutral$195+4.4%
Jun 30, 2026Upgrade
TFC logoTTruist
Hold → Buy$207+10.9%
Jun 25, 2026Upgrade
RY logoRRBC Capital Mkts
Sector Perform → Outperform$185-0.9%
May 18, 2026Resumed
RY logoRRBC Capital Mkts
Sector Perform$123-34.1%
Mar 26, 2026Upgrade
BMO logoBBMO Capital Markets
Market Perform → Outperform$130-30.4%
Feb 23, 2026Upgrade
JEF logoJJefferies
Hold → Buy$135-27.7%
Feb 18, 2026Upgrade
TD logoTTD Cowen
Hold → Buy$120-35.7%
Feb 17, 2026Downgrade
RRothschild & Co Redburn
Buy → Neutral$100-46.4%
Feb 12, 2026Downgrade
LLeerink Partners
Outperform → Market Perform$105-43.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murray CiaranDirectorNov 12 '26Sale200.1810,0002,001,7657,000Nov 16 04:15 PM
CIARAN MURRAYDirectorNov 12 '26Proposed Sale200.1810,0002,001,765Nov 12 04:07 PM
Murray CiaranDirectorNov 02 '26Sale205.663,452709,95617,000Nov 04 06:30 AM
Balfe Barry EdwardChief Executive OfficerNov 02 '26Sale206.665,1751,069,4419,291Nov 03 04:23 PM
Lyons EmerChief Accounting OfficerNov 02 '26Sale206.6626454,5581,217Nov 03 04:16 PM
Clerkin Nigel Bernard JohnChief Financial OfficerNov 02 '26Sale206.661,488307,5037,171Nov 03 04:11 PM
NIGEL CLERKINOfficerNov 02 '26Proposed Sale206.651,488307,501Nov 02 04:11 PM
CIARAN MURRAYDirectorNov 02 '26Proposed Sale205.663,452709,956Nov 02 04:10 PM
BARRY EDWARD BALFEOfficerNov 02 '26Proposed Sale206.655,1751,069,434Nov 02 04:06 PM
Lyons EmerChief Accounting OfficerOct 23 '26Sale182.3727249,604990Oct 26 06:57 AM
CLIMAX JOHN DRDirectorSep 16 '26Option Exercise125.745,005629,3297,092Sep 18 06:08 AM
CLIMAX JOHN DRDirectorSep 16 '26Sale175.005,005875,8752,087Sep 18 06:08 AM
McCague Eugene PacelliDirectorSep 17 '26Option Exercise125.743,255409,2847,066Sep 18 06:08 AM
McCague Eugene PacelliDirectorSep 17 '26Sale175.003,255569,6253,811Sep 18 06:08 AM
Murphy Ronan MartinDirectorSep 17 '26Option Exercise125.745,005629,3298,852Sep 18 06:07 AM
Murphy Ronan MartinDirectorSep 17 '26Sale175.005,005875,8753,847Sep 18 06:07 AM
EUGENE PACELLI MCCAGUEDirectorSep 17 '26Proposed Sale175.003,255569,625Sep 17 04:08 PM
RONAN MARTIN MURPHYDirectorSep 17 '26Proposed Sale175.005,005875,875Sep 17 04:06 PM
JOHN CLIMAXDirectorSep 16 '26Proposed Sale175.005,005875,875Sep 16 04:10 PM
Whitaker Anne ClemDirectorAug 11 '26Sale164.29841138,168891Aug 12 05:02 PM
O'Neill JulieDirectorAug 11 '26Sale164.29915150,3263,515Aug 12 05:01 PM
Murray CiaranDirectorAug 11 '26Sale164.292,677439,80320,452Aug 12 05:00 PM
Murphy Ronan MartinDirectorAug 11 '26Sale164.29841138,1683,847Aug 12 05:00 PM
McCague Eugene PacelliDirectorAug 11 '26Sale164.29841138,1683,811Aug 12 04:59 PM
Grais LindaDirectorAug 11 '26Sale164.29841138,1696,162Aug 12 04:47 PM
CLIMAX JOHN DRDirectorAug 11 '26Sale164.29841138,1682,087Aug 12 04:47 PM
Clerkin Nigel Bernard JohnChief Financial OfficerAug 11 '26Sale164.292,267372,4455,881Aug 12 04:46 PM
ANNE WHITAKERDirectorAug 11 '26Proposed Sale164.29841138,170Aug 11 05:12 PM
LINDA SUE GRAISDirectorAug 11 '26Proposed Sale164.29841138,170Aug 11 05:10 PM
EUGENE PACELLI MCCAGUEDirectorAug 11 '26Proposed Sale164.29841138,170Aug 11 05:09 PM
JOHN CLIMAXDirectorAug 11 '26Proposed Sale164.29841138,170Aug 11 05:06 PM
RONAN MARTIN MURPHYDirectorAug 11 '26Proposed Sale164.29841138,170Aug 11 05:04 PM
JULIE ANN O'NEILLDirectorAug 11 '26Proposed Sale164.29915150,327Aug 11 05:02 PM
NIGEL CLERKINOfficerAug 11 '26Proposed Sale164.292,267372,451Aug 11 05:00 PM
CIARAN MURRAYDirectorAug 11 '26Proposed Sale164.292,677439,810Aug 11 04:58 PM
Balfe Barry EdwardChief Executive OfficerAug 10 '26Sale164.0738262,6764,804Aug 11 04:22 PM
BARRY EDWARD BALFEOfficerAug 10 '26Proposed Sale164.0738262,676Aug 10 04:02 PM
BARRY EDWARD BALFEOfficerMar 09 '26Proposed Sale105.132,862300,875Mar 09 05:14 PM
BARRY EDWARD BALFEOfficerMar 04 '26Proposed Sale109.2556661,837Mar 04 04:07 PM
ICON plc engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm specializes in the development, management, and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S., and Rest of World. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
CEO & DirectorMr. Barry Balfe
Founder & Independent Non-Executive DirectorDr. John Climax Ph.D.
Chief Financial OfficerMr. Nigel Clerkin A.C.A.
Chief Commercial OfficerMr. Steve Empoliti
Chief Accounting OfficerLyons Emer